cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Researchers' data advance cancer vaccines research
October 25th, 2005
Data on cancer vaccines are outlined in reports from the United Kingdom, Italy and United States. Study 1: Researchers review promising therapeutic approaches to vaccination for malignant disease in a recent issue of The Surgeon. According to a study from England, "Immunotherapy of cancer is now entering its second century. Much of our understanding of the complex interaction between tumors and the host immune system has come about because of technological and immunobiological advances in very recent years." "For some malignancies, such as bladder cancer and malignant melanoma, immunotherapy is becoming an accepted form of...
Source: cancer weekly (2005-10-25)
|
